Latin America Supraglottic Devices Market Outlook (2022-2033)

The Latin America Supraglottic Devices market size is expected to reach US$ 158.9 million by 2033 from US$ 126.9 million in 2025. The market is estimated to record a CAGR of 2.8% from 2026 to 2033.

Executive Summary and Latin America Supraglottic Devices Market Analysis:

The Latin America supraglottic devices market is gradually expanding, shaped by a mix of growing healthcare infrastructure in urban centers and ongoing efforts to improve emergency and surgical care across the region. Supraglottic airway devices are increasingly recognized as practical and efficient solutions for airway management, especially in hospitals and trauma centers where rapid intervention is critical. Their ease of use, minimal invasiveness, and ability to provide reliable airway control make them highly valuable in perioperative, emergency, and critical care settings.

The main driver for the market is the increased emphasis on patient safety and efficiency in the clinical process. Hospitals are using such equipment to avoid any potential hazards during anesthesia, enhance surgical results, and streamline work processes in busy hospitals. The private network of healthcare organizations and specialized surgical centers is another important force behind the market growth due to the introduction of new devices and education programs. Nevertheless, financial constraints in publicly funded healthcare organizations may limit purchases of sophisticated or disposable equipment, and the quality of professional education may impact the use of devices in smaller hospitals. Difficulties in the distribution of equipment to remote regions and underdeveloped hospitals may also hinder its adoption. In spite of all possible challenges, growing awareness about airway safety, an increase in surgical procedures, and modernization efforts facilitate steady market growth in Latin America.

Latin America Supraglottic Devices Market - Strategic Insights:

Latin America Supraglottic Devices Market Segmentation Analysis:

Key segments that contributed to the derivation of the Latin America Supraglottic Devices market analysis are product type, usage type, application, patient type, and end user.

• By product type, the supraglottic devices market is segmented into laryngeal mask airways, laryngeal tubes, and other product types. The laryngeal mask airways segment dominated the market in 2025.
• Based on usage type, the supraglottic devices market is classified into disposable devices and reusable devices. The disposable devices segment dominated the market in 2025.
• In terms of application, the supraglottic devices market is categorized into anesthesia, critical care, emergency medicine, and other applications. The anesthesia segment dominated the market in 2025.
• By patient type, the supraglottic devices market is bifurcated into adult and pediatric. The adult segment dominated the market in 2025.
• Based on end user, the supraglottic devices market is segmented into hospitals, ambulatory surgical centers, emergency medical services, and other end users. The hospitals segment dominated the market in 2025.

Latin America Supraglottic Devices Market Drivers and Opportunities:

Uptrend in Minimally Invasive Airway Device Adoption

The Latin America supraglottic devices market is experiencing notable growth as hospitals and clinics increasingly adopt less invasive airway management solutions. Rising awareness of patient safety and the need to reduce procedural complications is driving healthcare providers to integrate supraglottic airway devices (SGAs) into standard protocols. Unlike traditional intubation, these devices allow rapid airway control without extensive pre-procedural preparation, making them particularly suitable for emergency care and high-turnover surgical environments.

Economic pressures and resource limitations are influencing adoption patterns. Many healthcare facilities in the region face high patient loads and limited availability of highly trained anesthesiologists, making SGAs a practical choice for maintaining care quality while improving operational efficiency. Devices that can be deployed quickly and with minimal equipment support are gaining favor, especially in facilities aiming to expand surgical and critical care services without proportionally increasing staffing requirements.

Clinical versatility is another key driver. Supraglottic devices are increasingly being used beyond traditional operating rooms, including in pre-hospital care, remote hospitals, and outpatient centers. Their ability to provide effective ventilation with minimal setup allows healthcare providers to manage a variety of patient conditions safely. Combined with growing confidence in minimally invasive procedures among regional clinicians, these factors are contributing to a sustained uptrend in SGA adoption across Latin America.

Accelerating Adoption of Training via Simulation Tools

Simulation-based training is emerging as a strategic tool for increasing the use of supraglottic airway devices in Latin America. Hospitals and medical schools are leveraging simulation labs to allow clinicians to practice device placement and troubleshoot challenging scenarios without risk to patients. This approach is particularly beneficial in regions where clinical exposure to advanced airway cases may be uneven, helping standardize skills across diverse healthcare settings.

Investment in structured training programs is rising. Workshops combining scenario-based learning with hands-on practice are helping staff master supraglottic device handling, including insertion in anatomically challenging situations and management of emergencies like airway obstructions. By providing repeated exposure to realistic patient scenarios, these programs improve both technical proficiency and decision-making, which is critical in high-pressure environments such as trauma care and intensive care units.

Simulation training is also enhancing long-term competency and adoption of SGAs. Low-cost simulators, peer-led workshops, and modular training programs make these learning tools accessible even in smaller hospitals or rural clinics. Clinicians report greater confidence in airway management following simulation exercises, which translates into broader acceptance and consistent use of supraglottic devices. As a result, the integration of simulation-based education is reinforcing skill development, patient safety, and market growth for SGAs throughout Latin America.

Latin America Supraglottic Devices Market Size and Share Analysis:

The Latin America Supraglottic Devices market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report evaluates important subsegments categorized within product type, usage type, application, patient type, and end user, highlighting their respective contributions to overall market performance.

By product type, the laryngeal mask airways subsegment dominated the supraglottic devices market in 2025. The dominance of laryngeal mask airways is driven by their ease of insertion, high success rate in securing the airway, reduced risk of complications compared to traditional intubation, and broad adoption in surgical and emergency settings, making them a key revenue contributor for manufacturers.

Based on usage type, the disposable devices subsegment led the market in 2025. Disposable supraglottic devices are preferred due to their reduced risk of cross-contamination, lower sterilization requirements, and convenience for high-volume clinical environments, which supports their widespread adoption across hospitals and emergency care facilities.

In terms of application, the anesthesia subsegment dominated the market in 2025. This leadership is attributed to the frequent use of supraglottic devices in elective and emergency surgical procedures, the increasing number of surgeries worldwide, and the clinical benefits of providing a safe and effective airway without the need for invasive intubation.

By patient type, the adult subsegment dominated the market in 2025. The preference for adult patients is driven by higher procedural volumes in adult surgeries, the established clinical efficacy of supraglottic devices in adult airway management, and increasing adoption in critical care and emergency settings.

Based on end user, the hospitals subsegment dominated the market in 2025. Hospitals lead due to their well-established anesthesia and critical care departments, access to advanced airway management devices, trained staff, and the capability to perform a high volume of surgical and emergency procedures requiring reliable airway management.

Latin America Supraglottic Devices Market Report Highlights:

Latin America Supraglottic Devices Market Report Coverage and Deliverables:

The "Latin America Supraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• Latin America Supraglottic Devices market size and forecast at regional and country levels for all market segments covered under the scope
• Latin America Supraglottic Devices market trends, as well as drivers, restraints, and opportunities
• Latin America Supraglottic Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Latin America Supraglottic Devices market
• Detailed company profiles, including SWOT analysis

Latin America Supraglottic Devices Market Geographic Insights:

The geographical scope of the Latin America Supraglottic Devices market report is divided into: Brazil, Mexico, Argentina, Colombia, Chile, and Peru. Mexico held the largest share in 2025.

Within Latin America, the dominant markets benefit from relatively advanced hospital infrastructure, rising surgical volumes, and a growing focus on modernizing perioperative and emergency care. Supraglottic airway devices are well-integrated within large hospitals, trauma centers, and specialized surgery departments due to their fast insertion and non-invasive nature, which gives obvious advantages over traditional intubation techniques.

The availability of skilled professionals and constant professional development contribute significantly to the promotion of the product. Physicians from reputable hospitals specialize in the use of supraglottic airway devices, ensuring appropriate implementation in the clinical environment. Private health care companies have an even higher potential for promoting innovative devices, considering that such organizations tend to be leaders in acquiring cutting-edge medical technologies and implementing proper airway management guidelines. Although advancements in cities have been significant, small hospitals and rural areas may experience certain problems associated with financial resources, staff qualification, and difficulties in obtaining medical devices. Despite such barriers, current trends of modernization, enhanced professional training, and the rising focus on patient safety and efficiency will continue to favor the introduction of supraglottic airway devices in key facilities of the area.

Latin America Supraglottic Devices Market Research Report Guidance:

• The report includes qualitative and quantitative data in the Latin America Supraglottic Devices market across product type, usage type, application, patient type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Latin America Supraglottic Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Latin America Supraglottic Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Latin America Supraglottic Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 12 cover Latin America Supraglottic Devices market segments by product type, usage type, application, patient type, end user, and geography across Brazil, Mexico, Argentina, Colombia, Chile, and Peru. They cover the market revenue, forecast, and factors driving the market.
• Chapter 13 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 14 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 15 provides detailed profiles of the major companies operating in the Latin America Supraglottic Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 16, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

Latin America Supraglottic Devices Market News and Key Development:

The Latin America Supraglottic Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Latin America Supraglottic Devices market are:

• In December 2025, Intersurgical Ltd. announced that it had entered an agreement to acquire the Acute Care and Interventional Urology businesses of Teleflex, a strategic move to expand its airway management portfolio (including supraglottic devices) and strengthen its global distribution network, including Latin America through enhanced partner access and product availability.
• In June 2023, Teleflex Incorporated announced a partnership with Insighters Medical for exclusive distribution of the Insighters Video Laryngoscope System, strengthening its airway management portfolio and supporting broader international distribution channels, including Latin American markets through its global commercial network.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• European Database on Medical Devices (EUDAMED)
• European Society of Cardiology (ESC)
• American College of Cardiology (ACC)
• American Heart Association (AHA)
• Company Websites
• Company Annual Reports
• Company Investor Presentations